Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business.
It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers.
[1][2] Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc.[3] (formerly BMS Medical Imaging), Progenics Pharmaceuticals (acquired 2020),[4][5] Inc. and EXINI Diagnostics AB (est.
1999, acquired 2020).
[6] Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden.